At the time the FDA said the drug resulted in "significant" weight loss but the agency said it was concerned about a possible risk of birth defects and an unknown impact on the heart.

WSJ: Federal Panel Approves Weight-Loss Drug Qnexa

Other rare birth defects have been suggested as a possible risk in some studies, but not others.

CNN: Antidepressants: Safe during pregnancy?